![Mario Alberto Accardi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mario Alberto Accardi currently works at Centessa Pharmaceuticals (Orexia) Ltd., as Director and Sierra MedTech Ltd., as Director from 2013.
Dr. Accardi also formerly worked at Centessa Pharmaceuticals Plc, as Chief Executive Officer & Director in 2026, Aitia, Inc., as Director, Inexia Ltd., as Director, vasopharm GmbH, as Member-Supervisory Board, and Entrepreneurs Fund Management LLP, as Associate.
Dr. Accardi received his graduate degree and doctorate degree from Imperial College London.
| Companies | Position | Start |
|---|---|---|
Orexia Therapeutics Ltd.
 Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Director/Board Member | 2019-01-01 |
Sierra MedTech Ltd.
 Sierra MedTech Ltd. Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on the development of innovative orthopaedic solutions | Director/Board Member | 2013-06-02 |
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Executive Officer | 2026-06-23 |
Inexia Ltd.
 Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Director/Board Member | - |
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Director/Board Member | - |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Director/Board Member | - |
Entrepreneurs Fund Management LLP
 Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Private Equity Analyst | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 8 |
|---|---|
Aitia, Inc.
Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services Provides analytics solutions for the healthcare industry | Commercial Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases | Health Technology |
Entrepreneurs Fund Management LLP
Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million. | Finance |
Inexia Ltd.
Inexia Ltd. Medical SpecialtiesHealth Technology Develops intranasal positive modulators | Health Technology |
Orexia Therapeutics Ltd.
Orexia Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops orally orexin positive modulators for the treatment of neurological diseases | Commercial Services |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Sierra MedTech Ltd.
Sierra MedTech Ltd. Medical SpecialtiesHealth Technology Operates as a medical technology company which focuses on the development of innovative orthopaedic solutions | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
